RT Book, Section
A1 Chong, Irene
A1 Cunningham, David
A2 Longo, Dan L.
SR Print(0)
ID 1128357277
T1 PANCREATIC CANCER
T2 Harrison's Hematology and Oncology, 2e
YR 2013
FD 2013
PB McGraw-Hill Education
PP New York, NY
SN 9780071814904
LK hemonc.mhmedical.com/content.aspx?aid=1128357277
RD 2024/04/19
AB Pancreatic  cancer  is  the  fourth  leading  cause  of  cancer  death  in  the  United  States  and  is  associated  with  a  poor  prognosis.  Endocrine  tumors  affecting  the  pancreas  are  discussed  in  Chap.  49.  Infiltrating  ductal  adenocarcinomas,  the  subject  of  this  chapter,  account  for  the  vast  majority  of  cases  and  arise  most  frequently  in  the  head  of  the  pancreas.  At  the  time  of  diagnosis,  85–90%  of  patients  have  inoperable  or  metastatic  disease,  which  is  reflected  in  the  5-year  survival  rate  of  only  5%  for  all  stages  combined.  An  improved  5-year  survival  of  up  to  20%  may  be  achieved  when  the  tumor  is  detected  at  an  early  stage  and  when  complete  surgical  resection  is  accomplished.